Clinical Trials Ontario to make Ontario a preferred location for global clinical trials

Clinical Trials Ontario has been officially launched, in an effort to boost to drug development in Ontario. This organization has been created as a province-wide entity to make Ontario the preferred location for global clinical trials activity while maintaining the highest ethical standards.

Brad Duguid, Minister of Economic Development & Innovation, said “Ontario is already a leader in bio-sciences and has one of the largest clusters in North America. This initiative is about sustaining the momentum we’ve built up and supporting a cutting-edge industry and good quality jobs.”

While Clinical Trials Ontario’s goal is to comprehensively make Ontario more competitive in the global clinical trials marketplace, its initial strategic approach is to streamline the ethics review and contract approval processes for industry-driven multi-site clinical trials in Ontario.

This will ensure cutting-edge healthcare discoveries and products are developed and nurtured in Ontario — keeping and creating high-value jobs in Ontario and providing Ontarians with early access to innovative approaches to health care through investigational drugs, devices and services.

Ronald Heslegrave, Executive Director, Clinical Trials Ontario, adds, ”In addition to helping Ontario become a strong competitor in the global industry-driven clinical trials market and providing better access to patients for innovative therapies, Clinical Trials Ontario will draw more industry investment to Ontario.”

This approach will also reduce duplication, shorten study start-up time, provide the highest quality of review and ensure the highest standard of patient safety while increasing patient access to investigational therapies.

best price for tadalafil Another popular cause of erectile dysfunction is peripheral neuropathy in which the nerves connected to erection enabling muscles. In on line levitra the flaccid, or soft erect, penile, the following conditions normally takes place: Small arteries might lead to a medical condition. It is only active when online generic cialis you fill your minds with sexual activities. This process of the degeneration of tissue (wear and lowest price on viagra tear) and the build up of scar tissue (accumulation of garbage) is really the root cause of all disability as documented by the CDC* (Centers for Disease Control and Prevention). The Canadian pharmaceutical industry is applauding the move. Nita Arora, Head of Clinical Operations, North America, Hoffmann-La Roche Limited, commented “We believe that the CTO will be a very important asset to Ontario in attracting Clinical Trials and the Research and Development investment that comes with it. Through the creation and funding of CTO, the Ontario government has shown that it understands the high level of global competition for the placement of Clinical Trials and has taken steps to be a world class player in this arena.”

Quick Facts

More than 5,200 clinical trials are underway in Ontario at any given time.

Every year, public and private researchers in Ontario conduct $13.5 billion in R&D across all sectors.

Currently, Ontario invests more than $500 million annually in basic and translational life sciences R&D.

The private sector invests almost $700 million yearly in applied health research, including clinical trials.

More than a million square feet and $1 billion in new research facilities have been completed in Ontario since 2005.

 Click here to visit the Clinical Trials Ontario website

About admin